Dechra Pharmaceuticals

Dechra Pharmaceuticals is one of the...

• FTSE 350.

Dechra Pharmaceuticals is a company listed under the stock ticker DPH (GB).

Dechra Pharmaceuticals has a direct presence in 3 countries.

Acquisition, funding and merger involving Dechra Pharmaceuticals.

• EQT has announced the acquisition of Dechra Pharmaceuticals  (posted on June 7 2023).

View the org chart displaying its 20 main executives

Most searched biographies at Dechra Pharmaceuticals

• Ian Page, Chief Executive Officer and Director
• Lisa Bright, Director
• Lawson Macartney, Senior Independent Director

Create your alert
to follow the executive moves at Dechra Pharmaceuticals.

Dechra Pharmaceuticals has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Dechra Pharmaceuticals

Social media about Dechra Pharmaceuticals

• Dechra Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Dechra Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Ian Page

Call Dechra Pharmaceuticals at +44 160...

View the org chart

Register to receive your alert

Report an error